Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    • News

  • June 2025 quarter CPI no roadblock to August RBA rate cut
    June 2025 quarter CPI no roadblock to August RBA rate cut
    • News

  • Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    • News

  • Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    • News

  • Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    • News

  • Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    • News

  • dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    • News

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

Latitude IPO successful but how big will the exit selldown be?

  • In Opinion
  • April 27, 2021
  • Samantha Freidin
Latitude IPO successful but how big will the exit selldown be?

The saying ‘third time’s a charm’ rings true for financial services company Latitude (ASX: LFS) who finally made their entrance to the public market last week after cementing themselves as the biggest ASX float of 2021  

This year’s offering marked Latitude’s third attempt at an IPO. Their first attempt was stalled in 2018 by investor sentiment around the Royal Commission into Banking and was followed by their second attempt in 2019 which attracted minimal broker interest. 

This time around, Latitude opted for their smallest offering which proved more attractive to investors, successfully raising just $150 million at a $2.60 Offer Price. It equated to a $2.6 billion float, a figure notably smaller than the  $3.5 billion attempted-float in 2019 and even smaller than the $8.2 billion paid by GE Capital for the business in 2015. 

Latitude is Australia’s third largest unsecured consumer lender, providing services to over 2.8 million customers and 3,400 merchant partners. Latitude’s business-to-consumer model came about in 2015 through the rebranding of GE Capital Finance, the largest retail finance company at the time.

Latitude prides itself on being more selective than its BNPL competitors, apparently rejecting two thirds of its potential customers of the 1 million that applied in 2020.

Afterpay on the other hand has reported a significant increase in customers over the last year, and is readying itself for US expansion.

Latitude’s view on installments as credit is what sets them apart. CEO Ahmed Fahour says that Latitude is “helping consumers with budgeting, there’s no question about it. We’re helping merchants with their marketing, no question about that as well. But it is credit at the end of the day, and an appropriate level of credit assessment or verification is required.” Latitude claims to conduct credit checks and service higher quality customers than other BNPL platforms. 

The Company’s largest pre-IPO shareholders KKR, Värde Partners and Deutsche Bank retained 66.4% of shares on listing but have voiced plans to sell down over time which may spook investors. This however is the reality of IPOs that get used as exit strategies which was the case when the previous two IPO attempts failed due a the lack of buyers. 

How far down they sell their shares will be of interest to most as it seems logical that interested investors wait on the sidelines until the sell-down stalls.

Latitude’s selectiveness might be a pro for investors but a deterrent for customers seeking easy, flexible financing options. Especially when there are plenty of sexier lending options than Alec Baldwin’s pitch. 

Ultimately time will tell if Latitude can keep up in the BNPL space which will dictate whether investors really can ‘do better’ with Latitude or head home early. 

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  •  
  •  
  •  
  •  
  • Opinion

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.